V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018803 | 260010038 | 1.6 | 66 | Disease modification (D) | 2019-10-13 | 2019-10-13 | ICE | 02 | N | 260010054 | ICE |
| 260018804 | 260010055 | 1.74 | 75 | null | 2018-01-28 | 2018-04-01 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | null | null | 260010422 | BLEOMYCIN + VINCRISTINE |
| 260018805 | 260018821 | 1.69 | 63 | Curative (C) | 2018-01-26 | 2018-02-09 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | N | N | 260010537 | CYCLOPHOSPHAMIDE |
| 260018806 | 260010058 | 1.7 | null | null | 2017-05-19 | 2017-07-04 | IPO | N | Y | 260010561 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018807 | 260014767 | 1.87 | null | Palliative (P) | 2017-05-06 | 2019-01-23 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260010646 | IPO |
| 260018808 | 260010079 | 1.62 | 61 | Curative (C) | 2015-02-08 | 2015-02-08 | Cisplatin + Radiotherapy | 02 | N | 260011239 | BENDAMUSTINE + OBINUTUZUMAB |
| 260018809 | 260017091 | 1.71 | 82 | Adjuvant (A) | 2019-11-13 | 2019-11-16 | CISPLATIN + EPIRUBICIN | N | N | 260011267 | GEMCARBO |
| 260018810 | 260010084 | 1.81 | null | Disease modification (D) | 2015-02-18 | 2015-04-11 | METHOTREXATE | N | N | 260011419 | CISPLATIN |
| 260018811 | 260017093 | 1.64 | 52.3 | Curative (C) | 2017-12-06 | 2018-01-17 | DHAP | null | N | 260011453 | ESHAP R |
| 260018812 | 260010089 | 1.56 | 61 | Curative (C) | 2019-11-14 | 2019-11-14 | BLEOMYCIN + VINCRISTINE | 02 | N | 260011893 | CVP |
| 260018813 | 260010090 | 1.81 | 60 | Palliative (P) | 2015-02-17 | 2015-02-18 | Carboplatin + Etoposide IV 3 day | 2 | N | 260011894 | CARBOPLATIN + ETOPOSIDE |
| 260018814 | 260010097 | null | 89.45 | Curative (C) | 2015-11-27 | 2016-12-18 | IFOSFAMIDE + PACLITAXEL | N | null | 260012022 | GEMCITABINE + PACLITAXEL |
| 260018815 | 260010099 | 1.8 | 88.8 | Palliative (P) | null | 2018-02-28 | DA-EPOCH-R | N | null | 260012162 | IPO |
| 260018816 | 260010103 | 1.58 | 94 | Curative (C) | 2017-05-02 | 2017-05-22 | Cyclophosphamide High Dose | N | N | 260012314 | NIVOLUMAB |
| 260018817 | 260014795 | 1.84 | 90.5 | Palliative (P) | 2016-02-24 | 2016-02-28 | GEMCARBO | 2 | N | 260014167 | CARBOPLATIN + ETOPOSIDE |
| 260018818 | 260010120 | 1.81 | 107 | Disease modification (D) | 2016-07-01 | 2016-07-11 | PAC-E | N | N | 260014651 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018819 | 260010134 | 0 | 67.6 | Palliative (P) | 2017-04-03 | 2017-04-09 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | null | 260016240 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018820 | 260010142 | 1.65 | null | null | 2017-11-09 | 2017-11-09 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 260017081 | CAPECITABINE + OXALIPLATIN |
| 260018821 | 260010148 | 1.64 | 56.6 | Curative (C) | null | 2020-01-02 | NIVOLUMAB | null | N | 260017955 | NIVOLUMAB |
| 260018822 | 260014811 | 1.91 | 89 | Palliative (P) | 2018-06-01 | 2018-06-03 | BLEOMYCIN + VINCRISTINE | 02 | N | 260019247 | IFOSFAMIDE + PACLITAXEL |
| 260018823 | 260010167 | 1.77 | 68.9 | Curative (C) | 2019-05-31 | 2019-10-04 | OSIMERTINIB | N | N | 260019465 | VINBLASTINE |
| 260018824 | 260014814 | 1.64 | 75 | Curative (C) | 2016-09-18 | 2016-09-18 | Cytarabine intrathecal | null | Y | 260019645 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260018825 | 260010172 | 1.81 | 79 | Curative (C) | 2014-12-10 | 2014-12-22 | IFOSFAMIDE + PACLITAXEL | 02 | N | 260019700 | PACLITAXEL |
| 260018826 | 260017114 | null | 70 | Curative (C) | 2014-02-21 | 2014-03-13 | Dasatinib | N | N | 260020079 | BENDAMUSTINE + OBINUTUZUMAB |
| 260018827 | 260017115 | 1.82 | 67.3 | null | null | 2018-03-08 | POMB/ACE | null | null | 260020285 | CARBO + THIOTEPA + TOPOTECAN |
| 260018828 | 260010184 | 1.75 | 49 | Disease modification (D) | 2018-02-10 | 2018-02-15 | BLEOMYCIN | N | N | 260021633 | POMB/ACE |
| 260018829 | 260010194 | 1.73 | 67.6 | Curative (C) | 2015-12-27 | 2016-05-27 | ESHAP R | 02 | N | 260022515 | REMODL TRIAL |
| 260018830 | 260014824 | 1.9 | 115.7 | Curative (C) | 2018-07-26 | 2018-07-29 | GEMCITABINE + TIP | 2 | N | 260023349 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260018831 | 260019125 | 1.84 | 93 | Palliative (P) | 2017-07-13 | 2017-08-10 | POMB | N | N | 260028027 | GEMCITABINE + OXALIPLATIN |
| 260018832 | 260014829 | 1.76 | 81.8 | Palliative (P) | 2016-09-18 | 2016-09-28 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | N | N | 260029516 | IVADO |
| 260018833 | 260010210 | 1.77 | 110 | Disease modification (D) | 2016-10-25 | 2016-11-15 | BLEOMYCIN | 2 | N | 260029897 | TEMOZOLOMIDE |
| 260018834 | 260018262 | 1.72 | 147 | Curative (C) | 2019-10-02 | 2019-10-03 | Fluorouricil + Folonic Acid (MdG) | N | null | 260000136 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260018835 | 260010218 | 1.55 | null | Curative (C) | 2017-04-19 | 2017-04-19 | Cisplatin + Radiotherapy | N | null | 260006709 | CISPLATIN + RT |
| 260018836 | 260010223 | 1.81 | 95.1 | Curative (C) | 2019-09-11 | 2019-09-17 | Vinblastine weekly | N | N | 260007145 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260018837 | 260010226 | 1.78 | 67.4 | Palliative (P) | 2018-02-23 | 2018-03-04 | ACE (germ cell) | 2 | N | 260007252 | CARBOPLATIN + PACLITAXEL |
| 260018838 | 260010228 | 1.75 | 68.8 | Curative (C) | 2016-05-11 | 2016-05-14 | GEMCITABINE + TIP | N | N | 260007814 | LANREOTIDE |
| 260018839 | 260010241 | 1.65 | 80 | Curative (C) | 2017-04-26 | 2017-04-27 | Carboplatin + Etoposide IV 3 day | N | N | 260019019 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018840 | 260010245 | 1.82 | 115 | Curative (C) | 2019-12-07 | 2019-12-11 | VIP | 02 | N | 260022120 | IFOSFAMIDE + PACLITAXEL |
| 260018841 | 260012527 | null | 112.3 | Palliative (P) | null | 2017-04-22 | Rituximab | 1 | null | 260010969 | RITUXIMAB |
| 260018842 | 260006469 | 1.71 | 80 | Adjuvant (A) | 2016-01-20 | 2017-08-21 | Rituximab (Maintenance) | N | null | 260011994 | RITUXIMAB |
| 260018843 | 260006473 | 1.8 | null | Palliative (P) | 2019-06-12 | 2019-06-25 | Rituximab (Maintenance) | 02 | N | 260012162 | RITUXIMAB |
| 260018844 | 260006479 | 1.64 | null | Palliative (P) | 2018-11-06 | 2018-11-10 | Rituximab | 02 | null | 260012548 | RITUXIMAB |
| 260018845 | 260006483 | 1.75 | 71.4 | Palliative (P) | 2015-04-07 | 2015-04-07 | Rituximab | 02 | N | 260012573 | RITUXIMAB |
| 260018846 | 260006496 | 1.68 | 66.9 | Disease modification (D) | 2018-04-01 | 2018-04-01 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260013256 | RITUXIMAB |
| 260018847 | 260006500 | 1.76 | 71 | Disease modification (D) | 2016-09-01 | 2017-06-02 | Rituximab (Maintenance) | N | N | 260013428 | RITUXIMAB |
| 260018848 | 260006547 | 1.78 | 119.45 | Disease modification (D) | 2016-11-15 | 2017-08-08 | Rituximab | N | N | 260015694 | RITUXIMAB |
| 260018849 | 260006566 | 0 | 77.7 | Adjuvant (A) | 2017-06-25 | 2018-01-17 | Rituximab | null | null | 260015840 | RITUXIMAB |
| 260018850 | 260006596 | 1.78 | 95.5 | Disease modification (D) | 2014-08-08 | 2014-08-08 | Rituximab | 02 | N | 260016181 | RITUXIMAB |
| 260018851 | 260006609 | 1.69 | 80.2 | Disease modification (D) | 2019-11-17 | 2019-11-21 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260016286 | RITUXIMAB |
| 260018852 | 260006619 | null | 87.7 | Disease modification (D) | 2016-03-21 | 2016-11-03 | Rituximab | N | N | 260016358 | RITUXIMAB |